Data for Healthcare
How to apply data to increase efficiency, lower costs, and improve patient care.
-Vo.png)
Data for Healthcare, Thursday 10 October 2019
08:00
Registration & Breakfast
Plenary Keynotes
08:35
Chairperson’s opening remarks
08:40
Data innovation in the American government: how the HHS effectively leverages data, technology and innovation to improve lives
09:00
Automating data: how AI and automation will impact the use of data applied to lab interconnectivity and sample analysis
09:20
Keynote Panel
Data strategies for R&D, addressing the importance of privacy, leveraging new technology and analytics for product commercialization, and integrating data into pharma companies.
10:20
Networking Coffee Break
Integrated Care
Data for Healthcare
11:00Engaging patients with data
How to develop effective strategies to engage patients in the selection of patient-centred outcomes and research questions
Data for Healthcare
11:40Bridging the gap: how data analysis can improve the assessment of patients’ needs and improve the access to care
Data for Healthcare
12:00Harnessing the power of integrated care: combining claims data with population insights to address ‘whole person health’ and enable truly patient-centric healthcare
12:20
Networking Lunch
ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30 minutes – attendees can select two roundtables to attend)
13:40
Roundtable: Incentivizing orphan drug innovation: how to motivate companies to develop orphan drugs through changes to reimbursement and tax incentives
Monika Schneider, Research Associate, Margolis Center For Health Policy, Duke University
13:40
Roundtable: Microbiomes as indicators of health: how the surrounding environment can impact human health, and an examination of the data supporting this as evidence
13:40
Roundtable: Mitigating the risk of mobile healthcare
How to secure data with the influx of healthcare apps and the move to patient interaction via mobile devices by conducting more frequent HIPAA security checks and penetration-testing / vulnerability-assessments of IT systems.
13:40
Roundtable: Multidisciplinary approaches: how to apply digital data to drug discovery, use new technology for data mining, and utilize machine learning
13:40
Roundtable: The impact of safety data collection: how to treat disease and improve the quality of life for patients while properly characterizing the effects of the drug
13:40
Roundtable: Using data to develop innovative telemedicine programs: sharing ideas for the creation and implementation of telehealth programs
13:40
Roundtable:Terabytes of data is not enough: building a better biobank via data product design, analytic services, data delivery, cloud-based analytic toolkits and other means
Telehealth
Data for Healthcare
14:50How telehealth is changing behavioral healthcare
Meeting the growing unmet demand of behavioral health care services, addressing barriers to adoption, and operational considerations for the unique clinical structure of telebehavioral health services.
Data for Healthcare
15:10Increasing health system efficiency: how to combine telemedicine, data, and artificial intelligence to drive an effective program
Disparate Health Systems
Data for Healthcare
15:30Addressing disparate health systems within populations: how to create partnerships between pharma, government, and health-disparate populations
Data for Healthcare
15:50EHR data for health disparity environments: Using clinical data from EHRs to develop clinical decision support algorithms to aid primary care physicians in health disparity zones such as inner city, r
Networking Coffee Break
Plenary Keynotes
Data Democratization
16:50
Keynote Fireside Chat: Data democratization: how to convey the value of data sharing to the industry, patients, and clinic
Kamal Sharma, Director, Strategic Initiatives, Director, Strategic Initiatives, Data Strategy & Services, Novartis Pharmaceutical
17:50
Closing remarks followed by networking drinks reception
More information soon.
last published: 11/Oct/19 15:25
Data for Healthcare, Friday 11 October 2019
08:00
Registration & Breakfast
Plenary Keynotes
09:20
C-level / SVP Healthcare Panel: data strategies to lower the cost of healthcare, encouraging collaboration between entities, and integrating EMR usage for increased efficiency
Jason Johnson, Senior Vice President, Chief Health Information Officer, Dana Farber Cancer Institute
Mayur Saxena, Chief Executive Officer, Droice Labs
10:20
Networking coffee break
12:20
Networking Lunch
13:40
Roundtable: AI for therapeutics: how to apply automation and machine learning to treatments and encourage the use of AI beyond drug discovery
13:40
ROUNDTABLE: AI integration: how incorporating AI into all phases of drug development from target discovery, to the recovery of failed projects is transforming pharma
13:40
Roundtable: Computational molecular dynamics: small molecule data approaches for modifying drugs and identifying targets
13:40
Roundtable: Data to Eliminate Health Disparities
Addressing the need for diversity in clinical trials and treatment by strategizing locations of research centers and clinics, creating accessible physician support, and using data to target individuals for outreach
13:40
Roundtable: Genomics in drug discovery: how to expedite the drug development through genomics and structural/cultural changes
13:40
Roundtable: Strategic data presentations for government support
How to engage government officials by shifting from the use of quantitative data (hard numbers) to qualitative data (telling the patient story) in your presentation.
Eve Bukowski, Vice President, Patient Advocacy, Education and Outreach, California Life Sciences Association - CLSA
13:40
Roundtable: Using data for clinical collaboration: how to accelerate research by encouraging collaboration between industry and patient advocates and by sharing data for use in clinical trial design
Kerry Leeson-Beevers, National Development Manager, Alstrom Syndrome U.K.
ROUNDTABLES (1-hour roundtable sessions split between 2 rounds of 30 minutes – attendees can select two roundtables to attend)
Regulatory Updates on Data
Data for Healthcare
14:50Big data in policy: addressing policy issues related to clinical trial designs, technological innovations, and the analysis of large scale health datasets
Data for Healthcare
15:10CBER’s “BEST” initiative: how to use healthcare and EHR data to support regulatory decision-making
15:30
End of Conference
last published: 11/Oct/19 15:25
Contact us
To sponsor or exhibit contact:
André Singer
t/ 646.619.1797
andre.singer@terrapinn.com
To speak:
Anna Bagley
t/ 646 619-1803
anna.bagley@terrapinn.com
Organiser
